TY  - GEN
AU  - Caltabiano,Rosario
AU  - Loreto,Carla
AU  - Caltabiano,Rosario
AU  - Loreto,Carla
TI  - Immunohistochemical Expression
SN  - books978-3-0365-0401-8
PY  - 2021///
CY  - Basel, Switzerland
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Medicine
KW  - bicssc
KW  - training exercise
KW  - NGAL
KW  - VDR
KW  - kidney
KW  - heart
KW  - immunohistochemistry
KW  - ABCB5
KW  - uveal melanoma
KW  - prognosis
KW  - metastasis
KW  - pericardium
KW  - cytokeratin
KW  - c-kit
KW  - PDGFR
KW  - initial lymphatics
KW  - macroH2A
KW  - prognostic factor
KW  - SLC22A12
KW  - URAT1
KW  - hypouricemia
KW  - uric acid transporters
KW  - excretion fraction of uric acid
KW  - Hsp27
KW  - Hsp60
KW  - Hsp70
KW  - Hsp90
KW  - molecular chaperone
KW  - chaperonopathies
KW  - thyroid
KW  - follicular adenoma
KW  - follicular carcinoma
KW  - differential diagnosis
KW  - carcinogenesis
KW  - matrix metalloproteinases
KW  - temporomandibular joint disorder
KW  - temporomandibular joint
KW  - DEN
KW  - liver
KW  - inflammation
KW  - ultra-structural changes
KW  - oxidative stress
KW  - EGCG
KW  - Vitamin D
KW  - prostate cancer
KW  - urinary tract malformations
KW  - megacystis
KW  - enteric nervous system
KW  - outcome and prognosis
KW  - WT1
KW  - human embryonal/fetal tissues
KW  - neoplastic tissue
KW  - n/a
N1  - Open Access
N2  - Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists' practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody-antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice
UR  - https://mdpi.com/books/pdfview/book/3867
UR  - https://directory.doabooks.org/handle/20.500.12854/76432
ER  -